Loading
Hyperglycemia / Composite intervention to address MetS / Hypertension · Interventional Study
ClinicalTrials.gov · August 19, 2026
Early or partial results. Treat as a signal, not a conclusion.
This is a registry record for a completed pilot randomized trial designed to test the feasibility of a multifaceted behavioral intervention for metabolic syndrome delivered in the emergency department setting. No results are reported in this registry record; the study enrolled 20 participants randomized to intervention or control and measured mean daily steps over a 3-month period as the primary outcome.
Interventional, Randomized, Parallel, Open label, Treatment purpose. Hypertension, Hyperglycemia, Dyslipidemia, Metabolic Syndrome, Obesity &Amp; Overweight, Diabetes, Hyperlipidemia, Emergency Medicine; age from 18 Years. Intervention: Intervention. Compared with: Control — No Intervention. n = 20. 1 site: United States.
This is a registry record for a completed pilot randomized trial designed to test the feasibility of a multifaceted behavioral intervention for metabolic syndrome delivered in the emergency department setting. No results are reported in this registry record; the study enrolled 20 participants randomized to intervention or control and measured mean daily steps over a 3-month period as the primary outcome.
No information provided on adherence, dropout rates, safety events, or any outcome findings.
No clinical impact can be assessed from this registry record alone, as results are not posted. Clinicians should await published results to evaluate whether this intervention approach is feasible and whether it affects physical activity or metabolic outcomes.
This is a pilot feasibility study with small enrollment (n=20) and no reported results; it is designed to establish feasibility of a composite intervention, not to test efficacy.
As stated by the source record.
Quoted from the source exactly as published.
No clinical impact can be assessed from this registry record alone, as results are not posted. Clinicians should await published results to evaluate whether this intervention approach is feasible and whether it affects physical activity or metabolic outcomes.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
What is missing. This record has no key findings. That is a gap in the analysis, not a judgement about the study.
Registry record from ClinicalTrials.gov (NCT07119658). This is a study registration, not published results. Lead sponsor: Indiana University. Recruitment status: COMPLETED. Phase: NA. Study type: INTERVENTIONAL. Enrollment: 20 participants (ACTUAL). Conditions: Hypertension, Hyperglycemia, Dyslipidemia, Metabolic Syndrome, Obesity & Overweight, Diabetes, Hyperlipidemia, Emergency Medicine. Interventions: BEHAVIORAL: Composite intervention to address MetS. Primary outcome measures: Mean daily steps , From enrollment to the end of the 3 month study period. Brief summary: The objective of this study is to pilot a multifaceted, optimized intervention for metabolic syndrome (MetS) in emergency department patients to establish feasibility. Participants (n=20) will be randomized to intervention or control (usual care). The composite intervention will include an educational video outlining the adverse effects of MetS and the benefit of walking, a written exercise prescription with a defined goal of walking 150 minutes per week, a Fitbit accelerometer device, resources for healthy eating practices, periodic text message reminders, and an urgent referral to primary care and our health system's Healthy Me clinic for follow-up visit. Investigators hypothesize that this approach will change patient understanding and motivation to increase physical activity and healthy eating habits.
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.